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ABSTRACT 
Filipendula ulmaria (L.) Maxim (meadowsweet) is a popular medicinal species that can 
be found throughout most Europe and Asia. The plant is known for its rich antioxidants 
content, having compounds such as flavonoids and ascorbic acid. Therefore, the aim of 
this work was to investigate if the flower extracts of Filipendula ulmaria (L.) Maxim 
have cell growth inhibitory activity in three human tumour cell lines representative of 
non-small cell lung cancer (NCI-H460), melanoma (A375-C5) and breast 
adenocarcinoma (MCF-7). One of the most potent extracts was selected to be further 
studied in the NCI-H460 cells, by investigating its antiproliferative potential, the effect 
on cell cycle profile and on programmed cell death. The obtained results showed that all 
the extracts inhibited the growth of the mentioned cell lines, with the one obtained by 
decoction being the most potent. Its effect on the NCI-H460 cells was due to a reduction 
in cellular proliferation, but not to alterations in programmed cell death. Interestingly, 
cellular treatment with the extract caused a statistically significant increase in the 
cellular levels of p21. Data obtained highlight the potential interest of F. ulmaria as a 
source of bioactive compounds. 
 
Keywords: Filipendula ulmaria (L.) Maxim; meadowsweet; tumour cell proliferation; 
p21.
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1. Introduction 
Plants have been used as traditional medicines throughout the centuries (Novais et al., 
2004) and nowadays they still play an important role in human therapy, according to the 
World Health Organization (WHO, 2002). Indeed, in some Asian and African countries 
80% of the population use traditional medicine (including plant based medicines) as 
primary health care (Panda, 2012).  
Filipendula ulmaria (L.) Maxim, commonly known as meadowsweet, is an interesting 
example of useful plants reported by several ethnobotanical surveys and can be found 
not only in the Iberian Peninsula, but also in other regions of most of Europe and 
Western Asia, such as Poland and Russia (Barros et al., 2013). Homemade remedies 
prepared from this species have been described since the late 16th and 17th centuries. 
Sweet tea is made from the dried flower and has been used for supportive treatment of 
common cold, relief of minor articular pain (analgesic properties), or to facilitate renal 
and digestive elimination functions. After an evaluation of the pharmacologic effects, in 
vitro and animal studies suggest that it has anti-inflammatory/immunomodulatory, 
antibacterial and anticarcinogenic activities (Rauha et al., 2000; Churin et al., 2008; 
Yildirim and Turker, 2009; Nesterova et al., 2009; Cwikla et al., 2010)  
To our knowledge, there are only two studies (not published in English), which have 
been carried out in order to investigate the tumour cell growth inhibitory activity of 
extracts from F. ulmaria. In one of those studies, carried out in Raji (Burkitt lymphoma 
cells), the authors state that ethanolic extracts of F. ulmaria were cytotoxic to those 
cells, at concentrations of 10 and 50 µg/ml (Peresun'ko et al., 1993). The other study 
indicates that the local administration of decoction flower extracts in mice with cervical 
dysplasia had beneficial effects in the frequency of squamous-cell carcinoma of the 
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cervix and vagina induced in mice by 7,12-dimethyl-benz(a)anthracene treatment 
(Spiridonov et al., 2005).  
Plant material gathered in Portugal has revealed rich antioxidants content, having 
compounds such as phenolic compounds, α-tocopherol and ascorbic acid. Regarding the 
phenolic compounds, phenolic acids (caffeic acid derivatives and gallic acid), flavonols 
(glycosides of quercetin and isorhamnetin) and ellagitannins (digalloyl-	  
hexahydroxydiphenol-glucose and trigalloyl digalloyl-hexahydroxydiphenol-glucose) 
have been described (Barros et al., 2013). 
In the present work, the tumour cell growth inhibitory potential of F. ulmaria flower 
extracts was investigated in three different human tumour cell lines: NCl-H460 (non-
small cell lung cancer), A375-C5 (melanoma) and MCF-7 (breast adenocarcinoma).  
The most potent extract was further studied regarding its effect in cellular proliferation, 
cell cycle and programmed cell death.  
 
2. Material and Methods 
2.1. Samples and preparation of the extracts  
The top 20 cm of the flowering stems and inflorescences with flowers fully open and 
functional of Filipendula ulmaria (L.) Maxim were collected in the Natural Park of 
Montesinho territory (Trás-os-Montes, North-eastern Portugal) in May 2009. Voucher 
specimens are kept at the Herbário da Escola Superior Agrária de Bragança (BRESA). 
The samples to be studied were lyophilized (Ly-8-FM-ULE, Snijders, Netherlands) and 
further submitted to four different extraction methodologies (Table 1). 
For infusion preparation the lyophilized material (1 g) was added to 200 ml of boiling 
distilled water and left to stand at room temperature for 5 min, and then filtered under 
reduced pressure.  
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For decoction preparation the lyophilized material (1 g) was added to 200 ml of distilled 
water, heated (heating plate, VELP scientific) and boiled for 5 min. The mixture was 
left to stand for 5 min and then filtered under reduced pressure. The obtained infusion 
and decoction extracts were frozen and lyophilized. 
For methanol and methanol:water (80:20 v:v) extracts preparation the lyophilized 
material (1 g) was extracted twice by stirring (25 ºC at 150 rpm) with 30 ml of methanol 
or methanol:water 80:20 (v:v), respectively, for 1 h and subsequently filtered through a 
Whatman No. 4 paper. The methanolic extracts were evaporated at 40 ºC (rotary 
evaporator Büchi R-210, Flawil, Switzerland) to remove methanol. In the case of 
methanol:water (80:20 v:v) extract, the aqueous phase was lyophilized.  
Stock solutions of all extracts were prepared in DMSO at a concentration of 100 mg/ml 
and further stored at -20ºC.   
 
2.2. Cell culture 
The human tumour cell lines used in the study were: NCl-H460 (non-small cell lung 
cancer, a kind gift from NCl, USA), A375-C5 (melanoma, ATCC) and MCF-7 (breast 
adenocarcinoma, ATCC). Cells were maintained in RPMI-1640 medium with 
ultraglutamine (Lonza, Pittsburgh, PA, USA) supplemented with 5% FBS (Gibco, 
Alfragide, Portugal), at 37ºC in a humidiﬁed incubator with 5 % CO2. All the 
experiments were performed with exponentially growing cells presenting more than 
90% cell viability. 
 
2.3.  Cell growth inhibition assay  
Cells were plated in 96-well plates at their previously determined optimal 
concentrations and incubated for 24 hours to adhere. In the case of NCI-H460 and 
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MCF-7 cells, the appropriate density was 5.0x104/ml, and in the case of A375-C5 cells 
the appropriate density was 7.5x104/ml. The sulforhodamine assay was adapted from 
the procedure used in the NCI’s in vitro anticancer drug screening (Vichai and Kirtikara 
2006; Neves et al.; 2011). Briefly, cells were treated with five serial dilutions of each 
extract, ranging from 25 µg/ml to 400 µg/ml. Following 48 h incubation with the extract 
(or immediately for the T0 plate), plates were fixed by adding ice-cold 10 % TCA (w/v, 
final concentration, Panreac, Barcelona, Spain) and stained with 1% SRB (Sigma 
Aldrich, St. Louis, MO, USA) in 1% (v/v) acetic acid. Bound dye was solubilised by 
adding 10mM Tris base solution (Sigma Aldrich, St. Louis, MO, USA) and finally the 
absorbance was measured at 510 nm in a microplate reader (BioTek® Synergy HT, 
Winooski, VT, USA).  
 
2.4. Preparation of cells for other analysis  
For the analysis of cellular proliferation, NCI-H460 cells were plated at 1.5x105 
cells/well in 6-well plates and incubated for 24 h. Cells were then treated with extract 2 
(obtained by decoction) at its GI50 and 2 x GI50 concentrations. Blank cells (treated with 
medium) or control cells (treated with DMSO, equivalent to the GI50 and 2 x GI50 of the 
extract B) were also included. Cells were then analysed for cellular proliferation, cell 
cycle profile, programmed cell death or protein expression. The percentage of viable 
cells in relation to Blank cells was also confirmed, by trypan blue exclusion, 48 h after 
the addition of the extracts to the cells. 
 
2.5. Cell proliferation analysis  
Cellular proliferation was analysed according to the protocol previously described 
(Palmeira et al., 2010). Briefly, following 47 h incubation, cells were treated with 10 
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µM BrdU (Sigma Aldrich, St. Louis, MO, USA) for 1 hour. Cells were then harvested 
and fixed in 4 % paraformaldehyde (Panreac, Barcelona, Spain) in PBS for 30 minutes 
at room temperature. Following centrifugation, cell pellets were re-suspended in PBS 
and stored at 4ºC until processed. Cell cytospins were prepared and incubated in 2 M 
HCl (Sigma Aldrich, St. Louis, MO, USA) for 20 minutes. Following incubation with 
mouse anti-BrdU antibody (diluted 1/10, Dako, Glostrup, Denmark) for 1 hour at room 
temperature, cells were further incubated with anti-mouse-Ig-FITC (diluted 1/100, 
Dako, Glostrup, Denmark) for 30 minutes, at room temperature. Slides were then 
mounted with Vectashield mounting medium (with DAPI). BrdU incorporation was 
analysed using a fluorescence microscope (Nikon eclipse E400 microscope, Melville, 
NY, USA) and a semi-quantitative evaluation was carried out by counting a minimum 
of 500 cells per slide. 
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2.6. Analysis of cell cycle distribution profile  
Following 48 h treatment, cells were fixed with ice-cold 70% ethanol (Fisher Scientific, 
Porto Salvo, Portugal) and stored at 4ºC for at least 12 h.  Prior to analysis, cells were 
re-suspended in PBS containing RNase A (0.1 mg/mL) (Sigma Aldrich, St. Louis, MO, 
USA) and propidium iodide (5 µg/mL) (Sigma Aldrich, St. Louis, MO, USA). Cellular 
DNA content was analysed by flow cytometry (Becton Dickinson FacsCalibur Flow 
cytometer, Billerica, MA, USA) and the percentage of cells in the G1, S and G2/M 
phases of the cell cycle (as well as the percentage of cells in the sub-G1 peak) were 
determined using the FlowJo 7.6.5 software (Tree Star, Inc., Ashland, OR, USA) after 
cell debris and aggregates exclusion and plotting at least 20000 events per sample 
(Vasconcelos et al., 2000).   
 
2.7. Analysis of programmed cell death 
Following 48 h of treatment, cell pellets were fixed with 4 % paraformaldehyde in PBS 
and further stored in PBS at 4ºC. TUNEL assay was carried out using the “in situ cell 
death detection kit – fluorescein” (Roche, Amadora, Portugal) according to 
manufacturer´s instructions. Briefly, cell cytospins were incubated in an ice cold 
“Permeabilization Solution” (0.1% Triton®X-100 in 0.1% sodium citrate, Promega, 
Madison, USA) for 2 minutes and then incubated with TUNEL reaction mix (1:20 
enzyme dilution, Roche, Amadora, Portugal) for 1 hour at 37ºC. Slides were mounted 
with Vectashield mounting medium (with DAPI). Cells were analysed using a 
fluorescence microscope and semi-quantitative evaluation of cells undergoing 
programmed cell death was assessed by counting a minimum of 500 cells per slide 
(Lima et al. 2004; Queiroz et al., 2013). 
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2.8. Protein expression analysis 
Following 48 h of treatment, cell pellets were lysed in Winman’s buffer (1% NP-40, 0.1 
M Tris -HCl pH 8.0, 0.15 M NaCl and 5 mM EDTA) complemented with protease 
inhibitor cocktail (Roche, Amadora, Portugal). The total protein content was quantified 
using the DC™ Protein Assay kit (Biorad, Hercules, CA), according to manufacturer’s 
instructions. Proteins (20 µg) were loaded on 12% SDS-PAGE gel and transferred into a 
nitrocellulose membrane (Amersham, Pittsburgh, PA, USA). The following primary 
antibodies were used: mouse anti-p53 (1:200, Thermo Scientific), mouse anti-p21 
(1:250, Calbiochem Darmstadt, Germany, rabbit anti-p-H2A.X (1:200, Santa Cruz 
Biotechnology, Heidelberg, Germany) and goat anti-Actin (1:2000, Santa Cruz 
Biotechnology, Heidelberg, Germany). The corresponding secondary antibodies were: 
anti-mouse IgG-HRP (1:2000, Santa Cruz Biotechnology, Heidelberg, Germany), anti-
rabbit IgG-HRP (1:2000, Santa Cruz Biotechnology, Heidelberg, Germany) or anti-goat 
IgG-HRP (1:2000, Santa Cruz Biotechnology, Heidelberg, Germany). The Amersham™ 
ECL Western Blotting Detection Reagents (GE Healthcare, Cleveland, Ohio, USA), the 
Amersham Hyperfilm ECL (GE Healthcare) and the Kodak GBX developer and fixer 
(Sigma, St. Louis, MO, USA) were used for signal detection, as previously described 
(Lima et al., 2006).  
  
2.9. Statistical analysis 
The results of the four tested extracts were analyzed using one-way analysis of variance 
(ANOVA) followed by Tukey’s HSD. In the remaining cases, results were analyzed by 
applying a Student’s t-test (paired test). All tests were carried out using SPSS v. 20.0 
program (SPSS Inc.), with P ≤ 0.05. 
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3. Results and Discussion 
3.1. Effect of the flower extracts on tumour cell growth inhibition 
All the extracts studied inhibited cell growth in the cell lines studied. Results obtained 
for the GI50 concentrations (which inhibit cell growth by 50%) indicate that the most 
potent extract for the NCI-H460 and for the A375-C5 cells was extract 2 (obtained by 
decoction). In the MCF-7 cell, extracts 2, 3 and 4 presented similar effect and were 
slightly more potent than extract 1 (Table 2). 
These results are in agreement with the ones obtained by the Russian study in the Raji 
cell line, in which extracts of F. ulmaria presented cytotoxic effects (Peresun'ko et al., 
1993). Nonetheless, the mechanisms behind such an effect are still not known. 
Therefore, extract 2 (obtained by decoction) was selected to be further tested in the 
NCI-H460 cell line. This cell line was selected for being a cell line representative of 
lung cancer, one of the most mortal types of cancer. 
 
3.2. Effect of extract 2 on NCI-H460 cellular proliferation 
The effect of this extract on the proliferation of NCI-H460 cells was assessed with the 
BrdU incorporation assay. Results clearly show that this extract reduces cellular 
proliferation. Nevertheless, the effect was most evident only with the 2xGI50 
concentration (Table 3).  
The lower effect on cellular proliferation obtained with the GI50 concentration could be 
justified by the fact that the SRB assay is based on the protein cellular content and not 
on cell number. Indeed, when the effect of the same concentrations of extract was 
studied regarding viable cell number, it was possible to conclude that the previously 
determined GI50 concentration did not reduce the viable cell number but that the 2xGI50 
concentration reduced viable cell number to less that 50% (Figure 1). This is probably 
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because a reduction in cellular protein content does not necessarily represent a reduction 
in cellular viability, at least not at the same time. This situation was already reported in 
similar studies with other natural matrices previoulsy carried out by some of the authors 
(Santos et al., 2013).  
 
3.3. Effect of extract 2 on NCI-H460 cell cycle profile 
Considering the reduction in cellular proliferation observed, the effect of the extract on 
cell cycle profile was investigated. Results (Figure 2) indicate that treatment with the 
2xGI50 concentration of the extract caused a slight increase in the G1 phase of the cell 
cycle but this was not considered statistically significant. Nonetheless, considering the 
previously obtained results in cellular proliferation, an increase in the number of cells in 
the G1 phase of the cell cycle would make sense. In fact, cell cycle arrests cause 
decrease in cellular proliferation (Chen et al., 2010).  
 
3.4. Effect of extract 2 on NCI-H460 programmed cell death 
The effect of this extract on programmed cell death was also analysed with the TUNEL 
assay. Results show that the extract did not cause any increase in programmed cell 
death, at the concentrations and time point analysed (Table 4). 
 
3.5. Effect of extract 2 on the expression levels of proteins involved in cellular 
proliferation and DNA damage, in NCI-H460 cells 
Given the previous results, which indicated that the 2xGI50 concentration of this extract 
reduced cellular proliferation and caused a slight alteration of the cell cycle profile at 
the studied time point, the effect of this concentrations and duration of treatment on the 
expression of cellular proteins involved in cell cycle was investigated. Results from 
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Western Blots clearly showed that this treatment caused a statistically significant 
increase in the cellular levels of p21, and a non-statistically significant increase of p53 
(Figure 3). 
The increase in p21 is particularly interesting, considering the indication that there was 
also a small increase in the number of cells in the G1 phase of the cell cycle, since p21 
is a G1-checkpoint cyclin-dependent kinase inhibitor (Abukhdeir and Park, 2008). It is 
well known that p21 expression is driven by p53 (Kuribayashi and El-Deiry, 2008) and 
therefore the increase in p53 found in our study could be the cause for the p21 increase. 
Nonetheless, it is known that the p21 tumor suppressor not only plays a role in p53 
signaling but interestingly also positively regulates p53 expression (Mirzayans et al., 
2012).  
As p53 also controls apoptosis, alterations in the programmed cell death levels of 
treated cells would be expected but were not found in the present study. It is possible 
that if the study was extended to other concentrations and times of treatment, alterations 
in cell death would also be observed. 
Since it is established that p53 expression could be increased as a result of DNA 
damage in wild-type p53 cells (Kuribayashi and El-Deiry, 2008), the present study was 
extended to look at the cellular protein levels of p-H2A.X following treatment with the 
extract.  An increase in p-H2A.X levels was observed, even though this was not 
statistically significant, which is a possible indication of DNA damage (Tanaka et al., 
2006). These results will need to be further confirmed with other specific assays for 
DNA damage. In fact, such a result is surprising considering the fact that the flowers 
from this plant are known for their rich antioxidants content (Barros et al., 2011; Barros 
et al., 2013). Nevertheless, those antioxidants might not be enough to avoid DNA 
damage, as least under the tested in vitro conditions.  
	   13	  
It would be interesting to isolate the compounds present in extract 2 of F. ulmaria and 
identify which one(s) are causing the inhibition of proliferation effect in the tumour 
cells.  
 
Overall, flower extracts of F. ulmaria inhibit the growth of the studied human tumour 
cell lines. The most potent extract was the one obtained by decoction, whose effect on 
the NCI-H460 cells was due to a reduction in cellular proliferation, causing an increase 
in the cellular levels of p21. Data obtained highlight the potential interest of this plant as 
a source of bioactive compounds. 
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a)Stock solutions of all extracts were prepared at 100mg/ml. 
Extract number Extraction method a) 
1 Infusion 
2 Decoction 
3 Methanol extaction 
4 Methanol:water 80:20 (v:v) extraction  
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Table 2. Determined GI50 concentrations of the Filipendula ulmaria flower extracts.  
Extract NCI-H460 MCF-7  A375-C5 
1 123.3 ± 5.4a 113.3 ± 7.2a 79.7 ± 6.2b 
2 70.0 ± 8.6c 96.0 ± 12.4b 63.3 ± 7.6c 
3 121.9 ± 17.7a 91.5 ± 13.8b 89.7 ± 12.8a 
4 79.7 ± 3.6b 96.3 ± 14.2b 83.7 ± 6.9a 
Values correspond to the mean ± S.E. of three independent experiments, carried out 
with duplicates.	  In each column different letters mean significant differences (p<0.05). 
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Table 3. Percentage of NCI-H460 cellular proliferation following treatment with extract 







Results are the mean ± S.E. of three independent experiments. 
Treatment % BrdU positive cells  
Blank 27.2 ± 3.5 
DMSO 31.2 ± 2.8 
2xDMSO 27.2 ± 3.5 
GI50 23.9 ± 1.8 
2xGI50 16.5 ± 2.9 
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Table 4. Percentage of NCI-H460 cells undergoing programmed cell death following 
treatment with extract 2, obtained by decoction of Filipendula ulmaria flowers. 
 




Results are the mean ± S.E. of three independent experiments. 
Treatment % of  cells undergoing programmed cell death 
Blank 2.9 ± 0.1 
DMSO 2.0 ± 0.4 
2xDMSO  1.5 ± 0.1 
GI50 2.0 ± 0.3 
2xGI50 2.5 ± 0.1 
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Figure 1. Effect of extract 2 on NCI-H460 viable cell number. 
Cells were treated for 48 h with medium (Blank), extract (GI50 and 2xGI50) or with the 
corresponding DMSO volumes (DMSO 1 and DMSO 2, respectively). Viable cell 
number was assessed with the Trypan blue exclusion assay. Results are the mean ± 
SEM of 3 independent experiments. 























Figure 2. Effect of extract 2 on NCI-H460 cell cycle profile. 
Blank DMSO 2xDMSO GI50 2xGI50 
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Cells were treated for 48 h with medium (Blank), extract (GI50 and 2xGI50) or with the 
corresponding DMSO volumes (DMSO and 2xDMSO, respectively). Results are the 
mean ± SE of 3 independent experiments. 







Figure 3. Effect of extract 2 on the expression levels of proteins involved in cellular 
proliferation and DNA damage, in NCI-H460 cells. 
Cells were treated for 48 h with medium (Blank), extract (GI50 and 2xGI50) or with the 
corresponding DMSO volumes (DMSO 1 and DMSO 2, respectively). Actin was used 
as loading control. Left panel shows a representative image of Western blot. Right panel 
shows the results of densitometric analysis expressed after normalization of the values 
obtained for each protein with the values obtained for actin and further expressed in 
relation to blank cells. Results are the mean ± SE of 3 independent experiments. * P ≤ 
0.05 between treatment and Blank. 
	  
	  
 
